Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
The DNA dependant protein kinase (DNA-PK) enzyme plays a major part in the repair of double stranded breaks induced by radiation and hence in the radio-resistance of tumour cells. Inhibitors of DNA-PK have been tested successfully in the past for their ability to sensitize cancer cells to the effect...
Main Authors: | Suraj Radhamani, Ph.D, Rejitha Suraj, Ph.D, Terri Meehan-Andrews, Ph.D, Jasim Al-Rawi, Christopher Bradley, Ph.D |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-07-01
|
Series: | Journal of Radiation Research and Applied Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1687850717300262 |
Similar Items
-
Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays
by: Fatemeh Sadeghi, et al.
Published: (2020-10-01) -
Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential
by: Felix Bürkel, et al.
Published: (2020-12-01) -
NU7441 Enhances the Radiosensitivity of Liver Cancer Cells
by: Chuanjie Yang, et al.
Published: (2016-05-01) -
Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial
by: Jordi Remon, MD, et al.
Published: (2020-09-01) -
Ovarian cancer: the Fallopian tube as the site of origin and opportunities for prevention
by: Sophia HL George, PhD, et al.
Published: (2016-05-01)